Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)

Clinical trial NCT02689362 · COMPLETED

Trial details

NCT number: NCT02689362
Sponsor: Eurofarma Laboratorios S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2017-08-08
Primary completion: 2018-08-09
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.